N-(3-(2-AZATRICYCLO(10.4.0.04,9-)HEXADECA-1(16),4,6,8,12,14-HEXAEN-10-YN-2-YL)-3-OXOPROPYL)-4-(2-BROMOACETYL)BENZAMIDE
UNII HB3P4APW2L
Substance Identification & Data
This profile provides standardized clinical and technical data for N-(3-(2-azatricyclo(10.4.0.04,9-)hexadeca-1(16),4,6,8,12,14-hexaen-10-yn-2-yl)-3-oxopropyl)-4-(2-bromoacetyl)benzamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) HB3P4APW2L.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2806047-36-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C27H21BrN2O3 MUHVYGNGBSFTGD-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for N-(3-(2-azatricyclo(10.4.0.04,9-)hexadeca-1(16),4,6,8,12,14-hexaen-10-yn-2-yl)-3-oxopropyl)-4-(2-bromoacetyl)benzamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.